NF-κB is described as a pro-inflammatory master switch determining production of various inflammatory mediators, triggering hypothalamic inflammation that can lead to altered hypothalamic control of metabolism to result in metabolic syndrome (Purkayastha et al., 2011, Zhang et al., 2008). The gene discussed is NFKB1; the disease is metabolic syndrome.